(a) Experimental design. Mice were intraperitoneally injected with saline or morphine 1x per day for 7 consecutive days. 1 week following the final injection P1 fractions were derived from NAc lysates.
(b and c) Western blots and quantification indicate that 1 week of morphine withdrawal does not affect PDZ-RhoGEF (t=0.3266, p>0.05), RhoA (t=0.1282, p>0.05), or Rock1 (t=0.02593, p>0.05) levels in NAc P1 fractions relative to saline-treated mice. n=12 saline mice, 11 morphine mice.
(d and e) Western blots and quantification indicate that 1 week of morphine withdrawal did not alter the expression of MAL (t=0.1606, p>0.05) or SRF (t=0.2064, p>0.05) in NAc P1 fractions. n=12 saline mice, 11 morphine mice
(f) Experimental design. Mice were intraperitoneally injected with saline or morphine 1x per day for 7 consecutive days. 1 week following the final injection S2 fractions were derived from NAc lysates.
(g and h) Western blots and quantification indicate that 1 week of morphine withdrawal did not affect the levels of PDZ-RhoGEF (t=1.991, p>0.05), RhoA (t=0.8842, p>0.05), or Rock1 (t=0.4595, p>0.05) in NAc S2 fractions. n=12 saline mice, 11 morphine mice.
(i and j) Western blots and quantification indicate that 1 week of morphine withdrawal did not alter the expression of MAL (t=0.4299, p>0.05) or SRF (t=1.918, p>0.05) in NAc S2 fractions. n=12 saline mice, 11 morphine mice.
(k) Experimental design. Mice were intraperitoneally injected with saline or morphine 1x per day for 7 consecutive days. 1 week following the final injection P2 fractions were derived from NAc lysates.
(l and m) Western blots and quantification indicate that 1 week of morphine withdrawal did not affect the levels of PDZ-RhoGEF (t=0.4244, p>0.05), RhoA (t=0.3352, p>0.05), or Rock1 (t=0.07281, p>0.05) in NAc P2 fractions. n=12 saline mice, 11 morphine mice.
All summary data are the mean + SEM.